These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17164384)

  • 1. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.
    Cicek MS; Nock NL; Li L; Conti DV; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1331-6. PubMed ID: 15298954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.
    Huang SP; Chou YH; Wayne Chang WS; Wu MT; Chen YY; Yu CC; Wu TT; Lee YH; Huang JK; Wu WJ; Huang CH
    Cancer Lett; 2004 Apr; 207(1):69-77. PubMed ID: 15050735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
    J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.
    John EM; Schwartz GG; Koo J; Van Den Berg D; Ingles SA
    Cancer Res; 2005 Jun; 65(12):5470-9. PubMed ID: 15958597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
    Ntais C; Polycarpou A; Ioannidis JP
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1395-402. PubMed ID: 14693728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
    Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Moczulski D; Klupa T; Kozek E; Sieradzki J
    Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):505-9. PubMed ID: 14714273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
    Mittal RD; Manchanda PK; Bhat S; Bid HK
    BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS; Isaacs SD; Isaacs WB; Bova GS
    J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.